Nab-paclitaxel + Carboplatin Clinical Trials
3 recruitingDrug
Phase 23Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Stage 4 NSCLCNon Small Cell Lung Cancer (Squamous or Non Squamous)
Eikon Therapeutics750 enrolled10 locationsNCT07365319
Recruiting
Phase 2
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
Triple-Negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital414 enrolled1 locationNCT04159142
Recruiting
Phase 2
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
Breast CancerTriple-Negative Breast CancerNab-paclitaxel
Hebei Medical University Fourth Hospital520 enrolled1 locationNCT04138719